eli lilly news glp-1 Is More Than Drugs. The Stock Looks Attractive FDA approves Foundayo, Eli Lilly's

AUSTIN, Texas, July 24, 2025 (Newswire.com) - Why Delilah's GLP-1 Plans Dominate 2025 Weight Loss Trends What You'll Learn As 2025 ushers in a wave of data-driven, sustainable weight loss solutions, GLP-1 treatments have emerged as the cornerstone of metabolic health transformation

B12 injections are highly effective at eliminating brain fog, improving memory, and boosting mental focus

The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study

I couldnt get it